{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# KcetParser\n",
    "\n",
    "This notebook demonstrates some of the parsing functionality of the ``kcet`` package. This is intended to document some of the functionality for added clarity. Note that for using the package, all of this can be performed under the hood, so end users do not need to study these functions."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import os\n",
    "import sys\n",
    "sys.path.insert(0, os.path.abspath('..'))\n",
    "from kcet import CTParserByPhase, KcetParser"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[INFO] Reading protein kinase information from /home/peter/GIT/KCET/input/prot_kinase.tsv\n",
      "[INFO] ingested symbol_to_id_map with 522 entries such as {'NCBIGene:2870': 'GRK6'}\n",
      "[INFO] Ingested mesh_id list with 694 entries such as 'meshd000008' and 'meshd000069293', \n",
      "[INFO] Ingested _meshid2disease_map with 694 entries\n",
      "[INFO] Ingested meshid2disease_map with 514 entries\n",
      "[INFO] Ingested pki_to_kinase with 83 entries\n"
     ]
    }
   ],
   "source": [
    "kcet = KcetParser()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Gene symbol to gene id map"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "CDK20 ncbigene23552\n",
      "RIPK2 ncbigene8767\n",
      "TGFBR1 ncbigene7046\n",
      "PIK3C3 ncbigene5289\n",
      "TYRO3 ncbigene7301\n"
     ]
    }
   ],
   "source": [
    "[print(key, value) for key, value in list(kcet.get_symbol_to_id_map().items())[:5]];"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## MeSH Id to Disease label map"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "meshd000008 Abdominal Neoplasms\n",
      "meshd000069293 Plasmablastic Lymphoma\n",
      "meshd000069295 Mammary Analogue Secretory Carcinoma\n",
      "meshd000069584 Unilateral Breast Neoplasms\n",
      "meshd000070779 Giant Cell Tumor of Tendon Sheath\n"
     ]
    }
   ],
   "source": [
    "[print(key, value) for key, value in list(kcet.get_mesh_to_disease_map().items())[:5]];"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Gene symbol to target-development level (TDL) map"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "AAK1 Tchem\n",
      "AATK Tbio\n",
      "ABL1 Tclin\n",
      "ABL2 Tchem\n",
      "ACVR1 Tchem\n"
     ]
    }
   ],
   "source": [
    "[print(key, value) for key, value in list(kcet.get_symbol_to_tdl_map().items())[:5]];"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Protein kinase inhibitor (PKI) to protein kinase map\n",
    "The list of protein kinases represent kinases that are inhibited by the indicated PKI."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "PKI ['PK']\n",
      "abemaciclib ['CDK4', 'CDK6']\n",
      "acalabrutinib ['BTK']\n",
      "actinomycin D ['DDR2']\n",
      "afatinib ['EGFR', 'ERBB2']\n"
     ]
    }
   ],
   "source": [
    "[print(key, value) for key, value in list(kcet.get_pki_to_kinase_list_dict().items())[:5]];"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# CTParserByPhase\n",
    "\n",
    "### Parsing the yactp file\n",
    "\n",
    "CTParserByPhase ingests the output of the yactp parser.\n",
    "\n",
    "[Yet Another Clinical Trials Parser](https://github.com/monarch-initiative/yactp) (yatcp) gets information about Clinical Trials involving a specified list of medications. This data includes information about the diseases being treated with the medications. We interpret any clinical trial as being an indication of scientific interest in treating a disease with a medication, and we interpret a Phase 4 trial as an indication that evidence exists (in a previous Phase 3 trial) that the medication may be effective against the disease.\n",
    "\n",
    "See the README for details on ``yactp``. \n",
    "\n",
    "We use a small example file that is created from the ``example.txt`` file in the ``yactp`` repository and is\n",
    "located in the ``example`` subdirectory of this repository. The file has a toy dataset representing two protein-kinase inhibitors."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "ctfile = os.path.abspath(os.path.join(os.pardir, 'example', 'clinical_trials_by_phase.tsv'))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "In the first example, we do not indicate the year, which defaults to the current year (2020 at the time of this writing)."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[INFO] Parsed data for the following medications:\n",
      "[INFO] imatinib\n",
      "[INFO] afatinib\n"
     ]
    }
   ],
   "source": [
    "parser = CTParserByPhase(clinical_trials=ctfile)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## All phases\n",
    "The following command is used to get studies from all phases (1, 2, 3, and 4). The columns ``cancer`` and ``mesh_id`` show the cancer that is treated by the protein kinase inhibitor in therr column ``pki``. The kinases that are the major target of the pki are shown in the columns ``kinase`` with the associated NCBI Gene id in the column ``gene.id``. The ``nct`` column shows the study ids of the corresponding study or studies in the phase shown in the ``phase`` column. The ``year`` column shows the **earliest** start year of the list of studies shown in the ``nct`` column. This information is parsed in the [yactp](https://github.com/monarch-initiative/yactp) project."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>cancer</th>\n",
       "      <th>mesh_id</th>\n",
       "      <th>kinase</th>\n",
       "      <th>gene.id</th>\n",
       "      <th>pki</th>\n",
       "      <th>nct</th>\n",
       "      <th>phase</th>\n",
       "      <th>year</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Carcinoma, Non-Small-Cell Lung</td>\n",
       "      <td>meshd002289</td>\n",
       "      <td>EGFR</td>\n",
       "      <td>ncbigene1956</td>\n",
       "      <td>afatinib</td>\n",
       "      <td>NCT01999985;NCT03054038;NCT04448379;NCT0219189...</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>2009</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Carcinoma, Non-Small-Cell Lung</td>\n",
       "      <td>meshd002289</td>\n",
       "      <td>ERBB2</td>\n",
       "      <td>ncbigene2064</td>\n",
       "      <td>afatinib</td>\n",
       "      <td>NCT01999985;NCT03054038;NCT04448379;NCT0219189...</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>2009</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Carcinoma, Non-Small-Cell Lung</td>\n",
       "      <td>meshd002289</td>\n",
       "      <td>EGFR</td>\n",
       "      <td>ncbigene1956</td>\n",
       "      <td>afatinib</td>\n",
       "      <td>NCT03623750;NCT02716311;NCT03399669;NCT0247006...</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>2007</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Carcinoma, Non-Small-Cell Lung</td>\n",
       "      <td>meshd002289</td>\n",
       "      <td>ERBB2</td>\n",
       "      <td>ncbigene2064</td>\n",
       "      <td>afatinib</td>\n",
       "      <td>NCT03623750;NCT02716311;NCT03399669;NCT0247006...</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>2007</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Carcinoma, Non-Small-Cell Lung</td>\n",
       "      <td>meshd002289</td>\n",
       "      <td>EGFR</td>\n",
       "      <td>ncbigene1956</td>\n",
       "      <td>afatinib</td>\n",
       "      <td>NCT01814553;NCT01523587;NCT00949650;NCT0243872...</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>2008</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Carcinoma, Non-Small-Cell Lung</td>\n",
       "      <td>meshd002289</td>\n",
       "      <td>ERBB2</td>\n",
       "      <td>ncbigene2064</td>\n",
       "      <td>afatinib</td>\n",
       "      <td>NCT01814553;NCT01523587;NCT00949650;NCT0243872...</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>2008</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>Carcinoma, Non-Small-Cell Lung</td>\n",
       "      <td>meshd002289</td>\n",
       "      <td>EGFR</td>\n",
       "      <td>ncbigene1956</td>\n",
       "      <td>afatinib</td>\n",
       "      <td>NCT02514174;NCT02695290;NCT02208843;NCT0441320...</td>\n",
       "      <td>Phase 4</td>\n",
       "      <td>2014</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>Carcinoma, Non-Small-Cell Lung</td>\n",
       "      <td>meshd002289</td>\n",
       "      <td>ERBB2</td>\n",
       "      <td>ncbigene2064</td>\n",
       "      <td>afatinib</td>\n",
       "      <td>NCT02514174;NCT02695290;NCT02208843;NCT0441320...</td>\n",
       "      <td>Phase 4</td>\n",
       "      <td>2014</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>Carcinoma</td>\n",
       "      <td>meshd002277</td>\n",
       "      <td>EGFR</td>\n",
       "      <td>ncbigene1956</td>\n",
       "      <td>afatinib</td>\n",
       "      <td>NCT02451553;NCT03652233;NCT01288430;NCT03878524</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>2011</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>Carcinoma</td>\n",
       "      <td>meshd002277</td>\n",
       "      <td>ERBB2</td>\n",
       "      <td>ncbigene2064</td>\n",
       "      <td>afatinib</td>\n",
       "      <td>NCT02451553;NCT03652233;NCT01288430;NCT03878524</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>2011</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>Carcinoma</td>\n",
       "      <td>meshd002277</td>\n",
       "      <td>EGFR</td>\n",
       "      <td>ncbigene1956</td>\n",
       "      <td>afatinib</td>\n",
       "      <td>NCT04183712;NCT03088059;NCT02541903;NCT0279515...</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>2007</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>Carcinoma</td>\n",
       "      <td>meshd002277</td>\n",
       "      <td>ERBB2</td>\n",
       "      <td>ncbigene2064</td>\n",
       "      <td>afatinib</td>\n",
       "      <td>NCT04183712;NCT03088059;NCT02541903;NCT0279515...</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>2007</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>Carcinoma</td>\n",
       "      <td>meshd002277</td>\n",
       "      <td>EGFR</td>\n",
       "      <td>ncbigene1956</td>\n",
       "      <td>afatinib</td>\n",
       "      <td>NCT01427478;NCT01523587;NCT01345682</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>2011</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>Carcinoma</td>\n",
       "      <td>meshd002277</td>\n",
       "      <td>ERBB2</td>\n",
       "      <td>ncbigene2064</td>\n",
       "      <td>afatinib</td>\n",
       "      <td>NCT01427478;NCT01523587;NCT01345682</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>2011</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>Carcinoma</td>\n",
       "      <td>meshd002277</td>\n",
       "      <td>EGFR</td>\n",
       "      <td>ncbigene1956</td>\n",
       "      <td>afatinib</td>\n",
       "      <td>NCT04132102</td>\n",
       "      <td>Phase 4</td>\n",
       "      <td>2018</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>Carcinoma</td>\n",
       "      <td>meshd002277</td>\n",
       "      <td>ERBB2</td>\n",
       "      <td>ncbigene2064</td>\n",
       "      <td>afatinib</td>\n",
       "      <td>NCT04132102</td>\n",
       "      <td>Phase 4</td>\n",
       "      <td>2018</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>Carcinoma, Squamous Cell</td>\n",
       "      <td>meshd002294</td>\n",
       "      <td>EGFR</td>\n",
       "      <td>ncbigene1956</td>\n",
       "      <td>afatinib</td>\n",
       "      <td>NCT01721525;NCT03652233</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>2012</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>Carcinoma, Squamous Cell</td>\n",
       "      <td>meshd002294</td>\n",
       "      <td>ERBB2</td>\n",
       "      <td>ncbigene2064</td>\n",
       "      <td>afatinib</td>\n",
       "      <td>NCT01721525;NCT03652233</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>2012</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>Carcinoma, Squamous Cell</td>\n",
       "      <td>meshd002294</td>\n",
       "      <td>EGFR</td>\n",
       "      <td>ncbigene1956</td>\n",
       "      <td>afatinib</td>\n",
       "      <td>NCT03088059;NCT02541903;NCT03695510;NCT0160802...</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>2007</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>Carcinoma, Squamous Cell</td>\n",
       "      <td>meshd002294</td>\n",
       "      <td>ERBB2</td>\n",
       "      <td>ncbigene2064</td>\n",
       "      <td>afatinib</td>\n",
       "      <td>NCT03088059;NCT02541903;NCT03695510;NCT0160802...</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>2007</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                            cancer      mesh_id kinase       gene.id  \\\n",
       "0   Carcinoma, Non-Small-Cell Lung  meshd002289   EGFR  ncbigene1956   \n",
       "1   Carcinoma, Non-Small-Cell Lung  meshd002289  ERBB2  ncbigene2064   \n",
       "2   Carcinoma, Non-Small-Cell Lung  meshd002289   EGFR  ncbigene1956   \n",
       "3   Carcinoma, Non-Small-Cell Lung  meshd002289  ERBB2  ncbigene2064   \n",
       "4   Carcinoma, Non-Small-Cell Lung  meshd002289   EGFR  ncbigene1956   \n",
       "5   Carcinoma, Non-Small-Cell Lung  meshd002289  ERBB2  ncbigene2064   \n",
       "6   Carcinoma, Non-Small-Cell Lung  meshd002289   EGFR  ncbigene1956   \n",
       "7   Carcinoma, Non-Small-Cell Lung  meshd002289  ERBB2  ncbigene2064   \n",
       "8                        Carcinoma  meshd002277   EGFR  ncbigene1956   \n",
       "9                        Carcinoma  meshd002277  ERBB2  ncbigene2064   \n",
       "10                       Carcinoma  meshd002277   EGFR  ncbigene1956   \n",
       "11                       Carcinoma  meshd002277  ERBB2  ncbigene2064   \n",
       "12                       Carcinoma  meshd002277   EGFR  ncbigene1956   \n",
       "13                       Carcinoma  meshd002277  ERBB2  ncbigene2064   \n",
       "14                       Carcinoma  meshd002277   EGFR  ncbigene1956   \n",
       "15                       Carcinoma  meshd002277  ERBB2  ncbigene2064   \n",
       "16        Carcinoma, Squamous Cell  meshd002294   EGFR  ncbigene1956   \n",
       "17        Carcinoma, Squamous Cell  meshd002294  ERBB2  ncbigene2064   \n",
       "18        Carcinoma, Squamous Cell  meshd002294   EGFR  ncbigene1956   \n",
       "19        Carcinoma, Squamous Cell  meshd002294  ERBB2  ncbigene2064   \n",
       "\n",
       "         pki                                                nct    phase  year  \n",
       "0   afatinib  NCT01999985;NCT03054038;NCT04448379;NCT0219189...  Phase 1  2009  \n",
       "1   afatinib  NCT01999985;NCT03054038;NCT04448379;NCT0219189...  Phase 1  2009  \n",
       "2   afatinib  NCT03623750;NCT02716311;NCT03399669;NCT0247006...  Phase 2  2007  \n",
       "3   afatinib  NCT03623750;NCT02716311;NCT03399669;NCT0247006...  Phase 2  2007  \n",
       "4   afatinib  NCT01814553;NCT01523587;NCT00949650;NCT0243872...  Phase 3  2008  \n",
       "5   afatinib  NCT01814553;NCT01523587;NCT00949650;NCT0243872...  Phase 3  2008  \n",
       "6   afatinib  NCT02514174;NCT02695290;NCT02208843;NCT0441320...  Phase 4  2014  \n",
       "7   afatinib  NCT02514174;NCT02695290;NCT02208843;NCT0441320...  Phase 4  2014  \n",
       "8   afatinib    NCT02451553;NCT03652233;NCT01288430;NCT03878524  Phase 1  2011  \n",
       "9   afatinib    NCT02451553;NCT03652233;NCT01288430;NCT03878524  Phase 1  2011  \n",
       "10  afatinib  NCT04183712;NCT03088059;NCT02541903;NCT0279515...  Phase 2  2007  \n",
       "11  afatinib  NCT04183712;NCT03088059;NCT02541903;NCT0279515...  Phase 2  2007  \n",
       "12  afatinib                NCT01427478;NCT01523587;NCT01345682  Phase 3  2011  \n",
       "13  afatinib                NCT01427478;NCT01523587;NCT01345682  Phase 3  2011  \n",
       "14  afatinib                                        NCT04132102  Phase 4  2018  \n",
       "15  afatinib                                        NCT04132102  Phase 4  2018  \n",
       "16  afatinib                            NCT01721525;NCT03652233  Phase 1  2012  \n",
       "17  afatinib                            NCT01721525;NCT03652233  Phase 1  2012  \n",
       "18  afatinib  NCT03088059;NCT02541903;NCT03695510;NCT0160802...  Phase 2  2007  \n",
       "19  afatinib  NCT03088059;NCT02541903;NCT03695510;NCT0160802...  Phase 2  2007  "
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_all = parser.get_all_phases()\n",
    "df_all.head(20)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Phase 4\n",
    "For the purposes of this project, we will regard all PKI/cancer combinations that have a phase 4 study as representing a confirmed relation\n",
    "that inhibition of the protein kinases targeted by the protein kinase inhibitor represents an effective treatment strategy for the cancer in question.\n",
    "The following command can be used to get a list with only phase 4 studies."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>cancer</th>\n",
       "      <th>mesh_id</th>\n",
       "      <th>kinase</th>\n",
       "      <th>gene.id</th>\n",
       "      <th>pki</th>\n",
       "      <th>nct</th>\n",
       "      <th>phase</th>\n",
       "      <th>year</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Carcinoma, Non-Small-Cell Lung</td>\n",
       "      <td>meshd002289</td>\n",
       "      <td>EGFR</td>\n",
       "      <td>ncbigene1956</td>\n",
       "      <td>afatinib</td>\n",
       "      <td>NCT02514174;NCT02695290;NCT02208843;NCT0441320...</td>\n",
       "      <td>Phase 4</td>\n",
       "      <td>2014</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Carcinoma, Non-Small-Cell Lung</td>\n",
       "      <td>meshd002289</td>\n",
       "      <td>ERBB2</td>\n",
       "      <td>ncbigene2064</td>\n",
       "      <td>afatinib</td>\n",
       "      <td>NCT02514174;NCT02695290;NCT02208843;NCT0441320...</td>\n",
       "      <td>Phase 4</td>\n",
       "      <td>2014</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Carcinoma</td>\n",
       "      <td>meshd002277</td>\n",
       "      <td>EGFR</td>\n",
       "      <td>ncbigene1956</td>\n",
       "      <td>afatinib</td>\n",
       "      <td>NCT04132102</td>\n",
       "      <td>Phase 4</td>\n",
       "      <td>2018</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Carcinoma</td>\n",
       "      <td>meshd002277</td>\n",
       "      <td>ERBB2</td>\n",
       "      <td>ncbigene2064</td>\n",
       "      <td>afatinib</td>\n",
       "      <td>NCT04132102</td>\n",
       "      <td>Phase 4</td>\n",
       "      <td>2018</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Carcinoma, Squamous Cell</td>\n",
       "      <td>meshd002294</td>\n",
       "      <td>EGFR</td>\n",
       "      <td>ncbigene1956</td>\n",
       "      <td>afatinib</td>\n",
       "      <td>NCT04132102</td>\n",
       "      <td>Phase 4</td>\n",
       "      <td>2018</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Carcinoma, Squamous Cell</td>\n",
       "      <td>meshd002294</td>\n",
       "      <td>ERBB2</td>\n",
       "      <td>ncbigene2064</td>\n",
       "      <td>afatinib</td>\n",
       "      <td>NCT04132102</td>\n",
       "      <td>Phase 4</td>\n",
       "      <td>2018</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>Lung Neoplasms</td>\n",
       "      <td>meshd008175</td>\n",
       "      <td>EGFR</td>\n",
       "      <td>ncbigene1956</td>\n",
       "      <td>afatinib</td>\n",
       "      <td>NCT04356118</td>\n",
       "      <td>Phase 4</td>\n",
       "      <td>2020</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>Lung Neoplasms</td>\n",
       "      <td>meshd008175</td>\n",
       "      <td>ERBB2</td>\n",
       "      <td>ncbigene2064</td>\n",
       "      <td>afatinib</td>\n",
       "      <td>NCT04356118</td>\n",
       "      <td>Phase 4</td>\n",
       "      <td>2020</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>Neoplasm Metastasis</td>\n",
       "      <td>meshd009362</td>\n",
       "      <td>EGFR</td>\n",
       "      <td>ncbigene1956</td>\n",
       "      <td>afatinib</td>\n",
       "      <td>NCT04356118</td>\n",
       "      <td>Phase 4</td>\n",
       "      <td>2020</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>Neoplasm Metastasis</td>\n",
       "      <td>meshd009362</td>\n",
       "      <td>ERBB2</td>\n",
       "      <td>ncbigene2064</td>\n",
       "      <td>afatinib</td>\n",
       "      <td>NCT04356118</td>\n",
       "      <td>Phase 4</td>\n",
       "      <td>2020</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>Neoplasms, Second Primary</td>\n",
       "      <td>meshd016609</td>\n",
       "      <td>EGFR</td>\n",
       "      <td>ncbigene1956</td>\n",
       "      <td>afatinib</td>\n",
       "      <td>NCT04356118</td>\n",
       "      <td>Phase 4</td>\n",
       "      <td>2020</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>Neoplasms, Second Primary</td>\n",
       "      <td>meshd016609</td>\n",
       "      <td>ERBB2</td>\n",
       "      <td>ncbigene2064</td>\n",
       "      <td>afatinib</td>\n",
       "      <td>NCT04356118</td>\n",
       "      <td>Phase 4</td>\n",
       "      <td>2020</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>Meningeal Carcinomatosis</td>\n",
       "      <td>meshd055756</td>\n",
       "      <td>EGFR</td>\n",
       "      <td>ncbigene1956</td>\n",
       "      <td>afatinib</td>\n",
       "      <td>NCT04356118</td>\n",
       "      <td>Phase 4</td>\n",
       "      <td>2020</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>Meningeal Carcinomatosis</td>\n",
       "      <td>meshd055756</td>\n",
       "      <td>ERBB2</td>\n",
       "      <td>ncbigene2064</td>\n",
       "      <td>afatinib</td>\n",
       "      <td>NCT04356118</td>\n",
       "      <td>Phase 4</td>\n",
       "      <td>2020</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>Leukemia</td>\n",
       "      <td>meshd007938</td>\n",
       "      <td>ABL1</td>\n",
       "      <td>ncbigene25</td>\n",
       "      <td>imatinib</td>\n",
       "      <td>NCT01491763;NCT00644878;NCT01660906;NCT0046192...</td>\n",
       "      <td>Phase 4</td>\n",
       "      <td>2003</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>Leukemia</td>\n",
       "      <td>meshd007938</td>\n",
       "      <td>PDGFRA</td>\n",
       "      <td>ncbigene5156</td>\n",
       "      <td>imatinib</td>\n",
       "      <td>NCT01491763;NCT00644878;NCT01660906;NCT0046192...</td>\n",
       "      <td>Phase 4</td>\n",
       "      <td>2003</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>Leukemia</td>\n",
       "      <td>meshd007938</td>\n",
       "      <td>PDGFRB</td>\n",
       "      <td>ncbigene5159</td>\n",
       "      <td>imatinib</td>\n",
       "      <td>NCT01491763;NCT00644878;NCT01660906;NCT0046192...</td>\n",
       "      <td>Phase 4</td>\n",
       "      <td>2003</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>Lung Neoplasms</td>\n",
       "      <td>meshd008175</td>\n",
       "      <td>ABL1</td>\n",
       "      <td>ncbigene25</td>\n",
       "      <td>imatinib</td>\n",
       "      <td>NCT03264794</td>\n",
       "      <td>Phase 4</td>\n",
       "      <td>2017</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>Lung Neoplasms</td>\n",
       "      <td>meshd008175</td>\n",
       "      <td>PDGFRA</td>\n",
       "      <td>ncbigene5156</td>\n",
       "      <td>imatinib</td>\n",
       "      <td>NCT03264794</td>\n",
       "      <td>Phase 4</td>\n",
       "      <td>2017</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>Lung Neoplasms</td>\n",
       "      <td>meshd008175</td>\n",
       "      <td>PDGFRB</td>\n",
       "      <td>ncbigene5159</td>\n",
       "      <td>imatinib</td>\n",
       "      <td>NCT03264794</td>\n",
       "      <td>Phase 4</td>\n",
       "      <td>2017</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                            cancer      mesh_id  kinase       gene.id  \\\n",
       "0   Carcinoma, Non-Small-Cell Lung  meshd002289    EGFR  ncbigene1956   \n",
       "1   Carcinoma, Non-Small-Cell Lung  meshd002289   ERBB2  ncbigene2064   \n",
       "2                        Carcinoma  meshd002277    EGFR  ncbigene1956   \n",
       "3                        Carcinoma  meshd002277   ERBB2  ncbigene2064   \n",
       "4         Carcinoma, Squamous Cell  meshd002294    EGFR  ncbigene1956   \n",
       "5         Carcinoma, Squamous Cell  meshd002294   ERBB2  ncbigene2064   \n",
       "6                   Lung Neoplasms  meshd008175    EGFR  ncbigene1956   \n",
       "7                   Lung Neoplasms  meshd008175   ERBB2  ncbigene2064   \n",
       "8              Neoplasm Metastasis  meshd009362    EGFR  ncbigene1956   \n",
       "9              Neoplasm Metastasis  meshd009362   ERBB2  ncbigene2064   \n",
       "10       Neoplasms, Second Primary  meshd016609    EGFR  ncbigene1956   \n",
       "11       Neoplasms, Second Primary  meshd016609   ERBB2  ncbigene2064   \n",
       "12        Meningeal Carcinomatosis  meshd055756    EGFR  ncbigene1956   \n",
       "13        Meningeal Carcinomatosis  meshd055756   ERBB2  ncbigene2064   \n",
       "14                        Leukemia  meshd007938    ABL1    ncbigene25   \n",
       "15                        Leukemia  meshd007938  PDGFRA  ncbigene5156   \n",
       "16                        Leukemia  meshd007938  PDGFRB  ncbigene5159   \n",
       "17                  Lung Neoplasms  meshd008175    ABL1    ncbigene25   \n",
       "18                  Lung Neoplasms  meshd008175  PDGFRA  ncbigene5156   \n",
       "19                  Lung Neoplasms  meshd008175  PDGFRB  ncbigene5159   \n",
       "\n",
       "         pki                                                nct    phase  year  \n",
       "0   afatinib  NCT02514174;NCT02695290;NCT02208843;NCT0441320...  Phase 4  2014  \n",
       "1   afatinib  NCT02514174;NCT02695290;NCT02208843;NCT0441320...  Phase 4  2014  \n",
       "2   afatinib                                        NCT04132102  Phase 4  2018  \n",
       "3   afatinib                                        NCT04132102  Phase 4  2018  \n",
       "4   afatinib                                        NCT04132102  Phase 4  2018  \n",
       "5   afatinib                                        NCT04132102  Phase 4  2018  \n",
       "6   afatinib                                        NCT04356118  Phase 4  2020  \n",
       "7   afatinib                                        NCT04356118  Phase 4  2020  \n",
       "8   afatinib                                        NCT04356118  Phase 4  2020  \n",
       "9   afatinib                                        NCT04356118  Phase 4  2020  \n",
       "10  afatinib                                        NCT04356118  Phase 4  2020  \n",
       "11  afatinib                                        NCT04356118  Phase 4  2020  \n",
       "12  afatinib                                        NCT04356118  Phase 4  2020  \n",
       "13  afatinib                                        NCT04356118  Phase 4  2020  \n",
       "14  imatinib  NCT01491763;NCT00644878;NCT01660906;NCT0046192...  Phase 4  2003  \n",
       "15  imatinib  NCT01491763;NCT00644878;NCT01660906;NCT0046192...  Phase 4  2003  \n",
       "16  imatinib  NCT01491763;NCT00644878;NCT01660906;NCT0046192...  Phase 4  2003  \n",
       "17  imatinib                                        NCT03264794  Phase 4  2017  \n",
       "18  imatinib                                        NCT03264794  Phase 4  2017  \n",
       "19  imatinib                                        NCT03264794  Phase 4  2017  "
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_phase_4 = parser.get_phase_4()\n",
    "df_phase_4.head(20)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Limit the time range\n",
    "By adding an argument for ``year``, the parser returns only studies that were started not later than the year in question.\n",
    "In the following example, we limit the year to 2012."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "targetYear = 2012\n",
    "parser2012 = CTParserByPhase(clinical_trials=ctfile, year=targetYear)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "df2012 = parser2012.get_all_phases()\n",
    "df2012.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "print(\"[INFO] We extracted %d cancer protein kinase links up to %d\" % (len(df2012), targetYear))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Get data for training\n",
    "For machine learning, we only require data that is formated with the gene id and the disease id. Also, we combine duplicate\n",
    "lines for the all_phases data frame. The following code shows how this is done."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "df_allphases_tr = parser.get_all_phases_for_training()\n",
    "df_allphases_tr.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "df_phase_4_tr = parser.get_phase_4_for_training()\n",
    "df_phase_4_tr.head()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Get validation data\n",
    "Here, we extract all positive studies published in Clinical Trials dot gov after the target year. It seems appropriate to use all phases for validation, not just phase 4, but for completeness, a separate function is provided to get phase 4 validation studies (see below)."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "df_validation_all = parser2012.get_validation_all_phases()\n",
    "df_validation_all.head(20)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "print(\"[INFO] We extracted %d protein kinase-cancer links published after the target year of %d\" \n",
    "      % (len(df_validation_all), targetYear))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Phase 4\n",
    "This function gets the phase 4 studies published after the target year."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "df_validation_p4 = parser2012.get_validation_phase_4()\n",
    "df_validation_p4.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "p38",
   "language": "python",
   "name": "p38"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
